標(biāo)題: Titlebook: Dermal Drug Selection and Development; An Industrial Perspe Lionel Trottet,Howard Maibach, MD Book 2017 Springer International Publishing A [打印本頁] 作者: 帳簿 時(shí)間: 2025-3-21 18:07
書目名稱Dermal Drug Selection and Development影響因子(影響力)
書目名稱Dermal Drug Selection and Development影響因子(影響力)學(xué)科排名
書目名稱Dermal Drug Selection and Development網(wǎng)絡(luò)公開度
書目名稱Dermal Drug Selection and Development網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Dermal Drug Selection and Development被引頻次
書目名稱Dermal Drug Selection and Development被引頻次學(xué)科排名
書目名稱Dermal Drug Selection and Development年度引用
書目名稱Dermal Drug Selection and Development年度引用學(xué)科排名
書目名稱Dermal Drug Selection and Development讀者反饋
書目名稱Dermal Drug Selection and Development讀者反饋學(xué)科排名
作者: STALL 時(shí)間: 2025-3-21 22:17 作者: avenge 時(shí)間: 2025-3-22 01:44 作者: amputation 時(shí)間: 2025-3-22 07:20 作者: BRACE 時(shí)間: 2025-3-22 10:38
Dermal Drug Development Strategies,he molecular basis of diseases as well as the push from payors to deliver better medicines compared to standard of care. This presents a strong opportunity for pharma companies who want to invest into dermal drug development projects as more assets and more therapeutic targets are becoming available作者: maroon 時(shí)間: 2025-3-22 15:57 作者: maroon 時(shí)間: 2025-3-22 19:50
Discusses how the science can be used for increased success .The authors show how the pharmaceutical industry faces the development of dermal drugs and provide the only book of its kind that describes how the industry develops and selects dermal drugs, complete with the challenges and opportunities 作者: Infinitesimal 時(shí)間: 2025-3-23 00:31 作者: 建筑師 時(shí)間: 2025-3-23 05:08 作者: occult 時(shí)間: 2025-3-23 06:27 作者: 硬化 時(shí)間: 2025-3-23 12:42
Introduction,y aspects of drug candidate selection in general to place into context the challenges that a drug discovery team would face for the selection of a dermal drug candidate. Finally, specific risks and opportunities for selecting such a dermal drug candidate are presented.作者: 我要威脅 時(shí)間: 2025-3-23 16:50
Assessing Drug Concentration in Skin: Direct and Indirect Methods,teristics: very specific for a drug or disease, possibly impractical, possibly not quantitative, possibly lacking sensitivity or possibly at a too early stage of development. They cannot, therefore, be applicable as versatile techniques for studying topical pharmacokinetics.作者: 緯線 時(shí)間: 2025-3-23 18:32 作者: 細(xì)絲 時(shí)間: 2025-3-24 00:27 作者: FANG 時(shí)間: 2025-3-24 03:32
https://doi.org/10.1007/978-3-319-59504-7drug development; dermal pharmacokinetics; dermal drugs; dermal drug candidate selection; dermatology作者: indignant 時(shí)間: 2025-3-24 08:57 作者: esculent 時(shí)間: 2025-3-24 12:40
Lionel Trottet,Howard Maibach, MDThe only book of its kind that describes how the industry develops and selects dermal drugs, complete with its challenges and opportunities.Discusses how the science can be used for increased success 作者: 共同生活 時(shí)間: 2025-3-24 18:11 作者: 揭穿真相 時(shí)間: 2025-3-24 19:53
Confucianism and SustainabilityHistorically most topical drug classes seem to have been originally developed following the pragmatic principle that, “if an existing drug with an interesting pharmacology is effective orally/systemically, and the target is in the skin, it could well work topically without giving side effects and, therefore, would deserve to be tried topically”.作者: 放氣 時(shí)間: 2025-3-24 23:28 作者: frivolous 時(shí)間: 2025-3-25 04:20 作者: nullify 時(shí)間: 2025-3-25 07:56 作者: Mammal 時(shí)間: 2025-3-25 13:06
The Thomist-Catholic View of FaithA key objective of the drug discovery project team is to discharge as much risk as possible for the selected candidate such that the best possible molecule can be progressed.作者: 減至最低 時(shí)間: 2025-3-25 17:24
The non-Objectivity of Faith and RevelationDeveloping and selecting a candidate molecule for an oral/systemic indication is not easy and the attrition rate remains high despite strong and widespread knowledge available to develop an effective risk discharge cascade to identify good candidate molecules.作者: 煩憂 時(shí)間: 2025-3-25 23:04 作者: 套索 時(shí)間: 2025-3-26 00:23
Topical Versus Oral/Systemic Drug Discovery,Over the past decades, the drug discovery process of the pharmaceutical industry has vastly improved.作者: 有雜色 時(shí)間: 2025-3-26 08:16 作者: Emmenagogue 時(shí)間: 2025-3-26 09:20 作者: 龍蝦 時(shí)間: 2025-3-26 16:26
Topical Drug Candidate Selection Criteria and Cascade,A key objective of the drug discovery project team is to discharge as much risk as possible for the selected candidate such that the best possible molecule can be progressed.作者: palliative-care 時(shí)間: 2025-3-26 18:41
Conclusions and Perspectives,Developing and selecting a candidate molecule for an oral/systemic indication is not easy and the attrition rate remains high despite strong and widespread knowledge available to develop an effective risk discharge cascade to identify good candidate molecules.作者: 貝雷帽 時(shí)間: 2025-3-26 22:58 作者: 生意行為 時(shí)間: 2025-3-27 04:00
Topical Vehicle Selection: Myths and Reality,risk of not engaging the target. Indeed to increase comfort that the target will be engaged one need to try fullfill as best as it can evidence of (1) sufficient compound on board for a desired time (i.e., PK within skin) and (2) demonstration of pharmacological activity [1].作者: Endoscope 時(shí)間: 2025-3-27 05:54 作者: 放逐某人 時(shí)間: 2025-3-27 11:18 作者: Cabinet 時(shí)間: 2025-3-27 14:51 作者: Antioxidant 時(shí)間: 2025-3-27 20:37 作者: HEPA-filter 時(shí)間: 2025-3-27 22:09 作者: Aura231 時(shí)間: 2025-3-28 05:40 作者: arthroplasty 時(shí)間: 2025-3-28 06:34
Modern Voluntarist Views of Faithhe molecular basis of diseases as well as the push from payors to deliver better medicines compared to standard of care. This presents a strong opportunity for pharma companies who want to invest into dermal drug development projects as more assets and more therapeutic targets are becoming available作者: MUTE 時(shí)間: 2025-3-28 10:24
https://doi.org/10.1007/978-1-349-19036-2otations and rules are listed in this chapter. Extra comments met during the course of various topical drug development programs are added too. Overall these quotations and rules, sometimes considered provocative, may be found helpful for program teams developing a topical molecule.作者: 意見一致 時(shí)間: 2025-3-28 16:16
https://doi.org/10.1007/978-1-349-18476-7ty for a particular skin disease will be compared to the easiness of topical drug development. The importance of the candidate molecule potency will be considered as well in comparison to its clinical efficacy.作者: 思想靈活 時(shí)間: 2025-3-28 19:42 作者: orthopedist 時(shí)間: 2025-3-29 00:39
Modern Voluntarist Views of Faithhe molecular basis of diseases as well as the push from payors to deliver better medicines compared to standard of care. This presents a strong opportunity for pharma companies who want to invest into dermal drug development projects as more assets and more therapeutic targets are becoming available.作者: 槍支 時(shí)間: 2025-3-29 04:17 作者: 議程 時(shí)間: 2025-3-29 07:55 作者: 分開 時(shí)間: 2025-3-29 14:45 作者: 反對 時(shí)間: 2025-3-29 19:35 作者: Arboreal 時(shí)間: 2025-3-29 21:19 作者: eustachian-tube 時(shí)間: 2025-3-30 02:23
Rozzana Sánchez Aragón,Rolando Díaz Loving in Greek), these visions can be an inspiration for quite practical activities on the ground, as steps towards their realization. As Wilde notes (in the quote above) this is a never-ending quest, as with each achievement, we recognize that there are further 978-1-4471-5821-9978-1-84800-350-7Series ISSN 1571-5035 Series E-ISSN 2524-4477 作者: Expostulate 時(shí)間: 2025-3-30 05:02 作者: 難解 時(shí)間: 2025-3-30 10:29
Ibha Suhani,Monika,Barkha Vaish,Pooja Singh,Rajeev Pratap Singh Fach Pr?vention/Gesundheitsf?rderung/Gesundheits?konomik so.?rzte, Pflegekr?fte und andere Mitarbeiter des Gesundheitswesens waren schon immer angehalten, rational zu handeln und Verschwendung zu vermeiden. Die Notwendigkeit einer expliziten Ausbildung in ?konomik wurde diesen Berufsgruppen jedoch 作者: 做作 時(shí)間: 2025-3-30 14:31
Research on Web 2.0 Digital Technologies in Education studies emerging, indicating that they have wide-ranging applications for teaching and learning. As such, they are regarded as having value-added educational offerings or affordances for students and staff (Banister, 2008; Heer, 2009; Minicha, 2009). Among such affordances are, for example, persona
